In vitro pharmacological profile of nonpeptide CRF1 receptor antagonists, CRA1000 and CRA1001
- 1 April 1999
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 371 (2-3) , 205-211
- https://doi.org/10.1016/s0014-2999(99)00120-x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammationEndocrinology, 1996
- Appetite-Suppressing Effects of Urocortin, a CRF-Related NeuropeptideScience, 1996
- CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissuesEndocrinology, 1995
- Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide induces anxiolytic effects in ratNeuroReport, 1994
- Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in ratsCellular and Molecular Neurobiology, 1994
- Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?Brain Research Reviews, 1990
- Mediation by Corticotropin Releasing Factor (CRF) of Adenohypophysial Hormone SecretionAnnual Review of Physiology, 1986
- Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed PatientsScience, 1984
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐IJournal of Neurochemistry, 1966